1-3 of 3
P. Andrew Futreal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm

Hannah Beird, C. Cameron Yin, Joseph D. Khoury, Sherry Pierce, Hussein A. Abbas, Li Zhao, Anna Skwarska, Muzaffar Qazilbash, Marina Konopleva, P. Andrew Futreal, Naveen Pemmaraju
Journal: Blood Advances
Blood Adv (2023) 7 (10): 2000–2003.
https://doi.org/10.1182/bloodadvances.2022007879
Published: 2023
Includes: Supplemental data
Journal Articles

Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL

Clinical Trials & Observations
Paolo Strati, Koichi Takahashi, Christine B. Peterson, Michael J. Keating, Philip A. Thompson, Naval G. Daver, Nitin Jain, Jan A. Burger, Zeev Estrov, Susan M. O'Brien, Hagop M. Kantarjian, William G. Wierda, P. Andrew Futreal, Alessandra Ferrajoli
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1533–1539.
https://doi.org/10.1182/bloodadvances.2019031336
Published: 2019
Journal Articles

Copy number alterations detected as clonal hematopoiesis of indeterminate potential

Koichi Takahashi, Feng Wang, Hagop Kantarjian, Xingzhi Song, Keyur Patel, Sattva Neelapu, Curtis Gumbs, Latasha Little, Samantha Tippen, Rebecca Thornton, Courtney D. DiNardo, Farhad Ravandi, Carlos Bueso-Ramos, Jianhua Zhang, Xifeng Wu, Guillermo Garcia-Manero, P. Andrew Futreal
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1031–1036.
https://doi.org/10.1182/bloodadvances.2017007922
Published: 2017
Includes: Supplemental data